Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18666485 | HEALTH TRACKING SYSTEM WITH MEAL GOALS | May 2024 | March 2026 | Allow | 22 | 2 | 0 | No | No |
| 18639124 | EVALUATION OF INGREDIENTS FOR TOXICITY WITH MACHINE LEARNING | April 2024 | December 2025 | Abandon | 20 | 1 | 0 | No | No |
| 18626099 | INTELLIGENT DECISION REASONING METHOD FOR TYPE-BASED DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASE, DEVICE, AND PRODUCT | April 2024 | December 2024 | Allow | 9 | 1 | 0 | No | No |
| 18624949 | DIAGNOSTIC IMAGING DEEP LEARNING SYSTEM AND METHOD | April 2024 | December 2025 | Abandon | 20 | 1 | 0 | No | No |
| 18696720 | METHOD AND SYSTEM FOR COLLECTING, RECORDING, AND TRANSMITTING CLINICAL INFORMATION WITH USEFULNESS-DRIVEN PROMPTS | March 2024 | March 2026 | Abandon | 24 | 0 | 1 | No | No |
| 18602776 | APPARATUS AND METHOD FOR IDENTIFYING REGIONS OF INTEREST DURING SLIDE DIGITIZATION | March 2024 | September 2024 | Allow | 7 | 1 | 0 | Yes | No |
| 18599934 | Blood Donation Collection System | March 2024 | September 2025 | Allow | 19 | 2 | 0 | No | No |
| 18421946 | HEALTH TESTING AND DIAGNOSTICS PLATFORM | January 2024 | July 2025 | Abandon | 18 | 1 | 0 | No | No |
| 18391300 | PRESCRIPTIVE NUTRITION-BASED IV AND IM INFUSION TREATMENT FORMULA CREATION SYSTEMS AND METHODS | December 2023 | June 2025 | Allow | 17 | 1 | 0 | Yes | No |
| 18525112 | FAILED IMAGE MANAGEMENT APPARATUS, OPERATION METHOD OF FAILED IMAGE MANAGEMENT APPARATUS, AND FAILED IMAGE MANAGEMENT SYSTEM | November 2023 | February 2026 | Allow | 26 | 3 | 0 | Yes | No |
| 18553314 | Artificial Intelligence For Determining A Patient's Disease Progression Level to Generate A Treatment Plan | September 2023 | December 2025 | Abandon | 27 | 1 | 0 | No | No |
| 18367281 | METHOD FOR REPURPOSING NDC CODES IN A PHARMACEUTICAL DATABASE FOR ALLERGENS | September 2023 | January 2025 | Abandon | 16 | 1 | 0 | No | No |
| 18219963 | Outcomes and Response Times for Patients in Critical Care Settings | July 2023 | September 2025 | Abandon | 27 | 1 | 0 | No | No |
| 18342273 | SYSTEM AND METHODS FOR SECURING A DRUG THERAPY | June 2023 | August 2025 | Allow | 25 | 3 | 0 | Yes | No |
| 18342155 | SYSTEMS AND METHODS FOR A COMPREHENSIVE ONLINE HEALTH CARE PLATFORM | June 2023 | October 2025 | Allow | 27 | 3 | 0 | Yes | No |
| 18325812 | SYSTEMS, METHODS, AND DEVICES FOR VIRTUALLY SUPERVISED MEDICAL WEIGHT LOSS TREATMENT PROGRAM ADMINISTERED VIA ON-DEMAND TELEHEALTH PROCTOR-OBSERVED PLATFORM | May 2023 | March 2025 | Allow | 21 | 3 | 0 | No | No |
| 18315008 | METHOD FOR OPERATING A SYSTEM AND A SYSTEM | May 2023 | June 2024 | Allow | 13 | 1 | 0 | Yes | No |
| 18136136 | BUSINESS TO CUSTOMER COMMUNICATION PORTAL | April 2023 | February 2026 | Allow | 34 | 3 | 1 | No | No |
| 18165306 | Diabetes Management Therapy Advisor | February 2023 | March 2024 | Allow | 14 | 2 | 0 | Yes | No |
| 18103146 | PREDICTING RESPONSE TO IMMUNOTHERAPY TREATMENT USING DEEP LEARNING ANALYSIS OF IMAGING AND CLINICAL DATA | January 2023 | March 2024 | Allow | 14 | 1 | 0 | No | No |
| 18083696 | PERIHEMATOMAL EDEMA ANALYSIS IN CT IMAGES | December 2022 | November 2023 | Allow | 10 | 1 | 0 | Yes | No |
| 18054732 | MONITORING ASSISTANCE DEVICE, MONITORING ASSISTANCE SYSTEM, MONITORING ASSISTANCE METHOD, AND STORAGE MEDIUM | November 2022 | March 2026 | Abandon | 40 | 3 | 0 | No | No |
| 17923795 | SYSTEM FOR TRACKING THE STATE OF A HOSPITAL RESOURCE | November 2022 | September 2025 | Abandon | 35 | 1 | 0 | No | No |
| 17977711 | SYSTEMS AND METHODS FOR MANAGING DIABETES CARE DATA | October 2022 | March 2024 | Allow | 17 | 1 | 0 | No | No |
| 17971428 | SYSTEM AND METHOD FOR POINT OF CARE BASED ON REAL-TIME PREDICTION OF ADDICTION TRIGGERS | October 2022 | August 2025 | Abandon | 34 | 1 | 1 | No | No |
| 17966766 | EVALUATION OF COMPREHENSIVE CLINICAL RISK PROFILES OF INFECTIOUS DISEASE IN REAL-TIME | October 2022 | January 2025 | Abandon | 27 | 1 | 0 | No | No |
| 17961898 | Personalised Medicine Treatment Program | October 2022 | March 2026 | Abandon | 41 | 2 | 0 | Yes | No |
| 17937874 | HEALTHCARE INFORMATION PROCESSING APPARATUS AND HEALTHCARE INFORMATION SERVER | October 2022 | March 2026 | Abandon | 41 | 3 | 0 | No | No |
| 17947829 | BLOOD DONATION COLLECTION SYSTEM | September 2022 | December 2023 | Allow | 15 | 1 | 0 | Yes | No |
| 17901880 | CIRCUIT SYSTEM WHICH EXECUTES A METHOD FOR PREDICTING SLEEP APNEA FROM NEURAL NETWORKS | September 2022 | April 2025 | Abandon | 32 | 1 | 0 | No | No |
| 17886957 | SYSTEM AND METHOD FOR PATIENT DATA PROCESSING DURING DIAGNOSIS AND THERAPY | August 2022 | June 2024 | Allow | 22 | 1 | 0 | Yes | No |
| 17880920 | PRESCRIPTIVE NUTRITION-BASED IV AND IM INFUSION TREATMENT FORMULA CREATION SYSTEMS AND METHODS | August 2022 | September 2023 | Allow | 14 | 2 | 1 | Yes | Yes |
| 17811591 | USER INTERFACE FOR NAVIGATING THROUGH PHYSIOLOGICAL DATA | July 2022 | October 2023 | Abandon | 16 | 2 | 0 | Yes | No |
| 17787589 | SMART DIAGNOSIS SYSTEM AND METHOD | June 2022 | August 2025 | Allow | 38 | 2 | 0 | Yes | No |
| 17804227 | HEALTH TESTING AND DIAGNOSTICS PLATFORM | May 2022 | November 2023 | Allow | 18 | 2 | 0 | No | No |
| 17739277 | COMPUTERIZED METHOD FOR DETERMINING NUTRITIONAL SUPPLEMENT DELIVERY | May 2022 | December 2025 | Abandon | 43 | 3 | 0 | No | No |
| 17738869 | IV COMPOUNDING SYSTEMS AND METHODS | May 2022 | November 2025 | Allow | 42 | 4 | 0 | Yes | No |
| 17724472 | CEREBRAL HEMORRHAGE ANALYSIS IN CT IMAGES | April 2022 | February 2025 | Abandon | 34 | 1 | 0 | No | No |
| 17702325 | GENERATION OF A TRANSACTION SET | March 2022 | October 2024 | Allow | 30 | 2 | 0 | Yes | No |
| 17677587 | HEALTH TESTING AND DIAGNOSTICS PLATFORM | February 2022 | September 2023 | Allow | 19 | 4 | 0 | Yes | No |
| 17671215 | INDIVIDUALLY CUSTOMIZED ALLERGY CREAM FOR INDIVIDUAL PATIENT PROFILE | February 2022 | June 2025 | Abandon | 40 | 2 | 0 | No | No |
| 17666817 | Medical Intelligence System and Method | February 2022 | September 2025 | Allow | 43 | 3 | 0 | Yes | No |
| 17566289 | Patient Post-Operation Improvement Prediction Using Machine Learning | December 2021 | November 2024 | Abandon | 35 | 1 | 0 | No | No |
| 17552867 | HEALTH TRACKING SYSTEM WITH MEAL GOALS | December 2021 | February 2024 | Allow | 26 | 2 | 0 | Yes | No |
| 17544511 | DEVICE AND METHOD FOR MOBILE MONITORING OF DRAINAGE CATHETER | December 2021 | August 2023 | Allow | 21 | 1 | 0 | Yes | No |
| 17457913 | INFORMATION PROCESSING APPARATUS, NON-TRANSITORY COMPUTER READABLE MEDIUM, AND INFORMATION PROCESSING METHOD | December 2021 | February 2026 | Abandon | 50 | 4 | 0 | Yes | No |
| 17535555 | SETTING AN AUTOMATIC WINDOW OF INTEREST BASED ON A LEARNING DATA ANALYSIS | November 2021 | March 2026 | Abandon | 52 | 5 | 0 | No | No |
| 17528089 | CRITERIA BASED ALARMS COORDINATION BETWEEN A NETWORK OF MEDICAL DEVICES | November 2021 | June 2024 | Allow | 31 | 1 | 0 | Yes | No |
| 17518006 | DATABASE AND MACHINE LEARNING IN RESPONSE TO PARALLEL SERIAL DUAL MICROFLUIDIC CHIP | November 2021 | April 2025 | Abandon | 41 | 1 | 1 | No | No |
| 17365142 | SYSTEMS AND METHODS FOR PATIENT RECORD MATCHING | July 2021 | November 2024 | Abandon | 41 | 1 | 1 | No | No |
| 17308937 | ANONYMOUS DATA PUBLISHING | May 2021 | October 2023 | Abandon | 30 | 1 | 0 | No | No |
| 17200839 | USER INTERFACE FOR NAVIGATING THROUGH PHYSIOLOGICAL DATA | March 2021 | May 2025 | Abandon | 50 | 2 | 0 | No | Yes |
| 17188200 | TRANSFER OF BREATHING ASSISTANCE APPARATUS DATA | March 2021 | March 2024 | Allow | 37 | 2 | 0 | Yes | No |
| 17174743 | SYSTEMS AND METHODS FOR PATIENT RECORD MATCHING | February 2021 | June 2024 | Abandon | 40 | 1 | 0 | No | No |
| 17163893 | Patient Management Based On Anatomic Measurements | February 2021 | February 2026 | Abandon | 60 | 6 | 0 | Yes | No |
| 17158145 | FAILED IMAGE MANAGEMENT APPARATUS, OPERATION METHOD OF FAILED IMAGE MANAGEMENT APPARATUS, AND FAILED IMAGE MANAGEMENT SYSTEM | January 2021 | August 2023 | Allow | 31 | 1 | 0 | Yes | No |
| 17122003 | ALGORITHM ORCHESTRATION OF WORKFLOWS TO FACILITATE HEALTHCARE IMAGING DIAGNOSTICS | December 2020 | February 2024 | Allow | 38 | 3 | 0 | Yes | No |
| 17109458 | MEDICAL CARE SUPPORT APPARATUS | December 2020 | March 2025 | Abandon | 52 | 4 | 0 | No | No |
| 17108348 | SYSTEM AND METHOD FOR GENERATING DIFFERENTIAL DIAGNOSIS IN A HEALTHCARE ENVIRONMENT | December 2020 | December 2023 | Abandon | 36 | 1 | 0 | No | No |
| 17102595 | ALGORITHM ORCHESTRATION OF WORKFLOWS TO FACILITATE HEALTHCARE IMAGING DIAGNOSTICS | November 2020 | August 2024 | Allow | 45 | 4 | 0 | Yes | No |
| 17089702 | EFFICIENT DETERMINATION OF A DATA ENTITY STORING HEALTHCARE DATA THROUGH MAPPED ENTRY AND/OR TRAVERSAL OF A SEMANTIC DATA STRUCTURE | November 2020 | March 2024 | Abandon | 40 | 1 | 1 | No | No |
| 17019056 | INTELLIGENT PROCESSING OF BULK HISTORIC PATIENT DATA | September 2020 | February 2026 | Abandon | 60 | 4 | 0 | Yes | Yes |
| 16998509 | SYSTEMS AND METHODS FOR PATIENT RECORD MATCHING | August 2020 | December 2023 | Abandon | 40 | 1 | 1 | No | No |
| 16958544 | AUTOMATED EXTRACTION OF STRUCTURED LABELS FROM MEDICAL TEXT USING DEEP CONVOLUTIONAL NETWORKS AND USE THEREOF TO TRAIN A COMPUTER VISION MODEL | June 2020 | January 2024 | Allow | 42 | 2 | 0 | Yes | No |
| 16954568 | METHOD AND SYSTEM FOR EVALUATING COMPLIANCE OF STANDARD CLINICAL GUIDELINES IN MEDICAL TREATMENTS | June 2020 | May 2024 | Abandon | 47 | 4 | 0 | Yes | No |
| 16891309 | RISK PREDICTION FOR COVID-19 PATIENT MANAGEMENT | June 2020 | September 2023 | Allow | 40 | 3 | 0 | Yes | No |
| 16888104 | METHOD AND SYSTEM FOR REMOTELY MONITORING THE PHYSICAL AND PSYCHOLOGICAL STATE OF AN APPLICATION USER USING ALTITUDE AND/OR MOTION DATA AND ONE OR MORE MACHINE LEARNING MODELS | May 2020 | December 2023 | Allow | 42 | 3 | 0 | No | No |
| 16840624 | System, Method and Apparatus for Performing Real-Time Virtual Medical Examinations | April 2020 | April 2024 | Allow | 48 | 8 | 0 | Yes | No |
| 16832142 | METHOD AND SYSTEM FOR PROVIDING INTERPRETATION INFORMATION ON PATHOMICS DATA | March 2020 | June 2023 | Allow | 38 | 6 | 0 | Yes | No |
| 16807946 | COMMUNICATION MODE SELECTION BASED UPON USER CONTEXT FOR PRESCRIPTION PROCESSES | March 2020 | March 2025 | Allow | 60 | 6 | 0 | Yes | No |
| 16623421 | METHOD AND SYSTEM FOR IMAGE ANALYSIS OF A MEDICAL IMAGE | December 2019 | December 2023 | Abandon | 48 | 1 | 0 | No | No |
| 16588881 | Tracking the Probability for Imminent Hypoglycemia in Diabetes From Self-Monitoring Blood Glucose (SMBG) Data | September 2019 | July 2025 | Abandon | 60 | 6 | 0 | Yes | No |
| 16557797 | METHODS AND SYSTEMS FOR COMPUTER-AIDED DIAGNOSIS WITH DEEP LEARNING MODELS | August 2019 | March 2024 | Allow | 54 | 4 | 2 | Yes | No |
| 16193078 | MANAGEMENT APPARATUS AND SYSTEM | November 2018 | June 2024 | Abandon | 60 | 8 | 0 | Yes | No |
| 15755096 | Systems And Methods For Genetic Analysis Of Metastases | February 2018 | October 2023 | Allow | 60 | 3 | 0 | Yes | Yes |
| 15420187 | Method and System for Entry, Transfer, Storage, Transmission and Retrieval of Medical, Health and Healthcare Related Data | January 2017 | January 2020 | Abandon | 36 | 2 | 1 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner SASS, KIMBERLY A..
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner SASS, KIMBERLY A. works in Art Unit 3686 and has examined 34 patent applications in our dataset. With an allowance rate of 44.1%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 42 months.
Examiner SASS, KIMBERLY A.'s allowance rate of 44.1% places them in the 9% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by SASS, KIMBERLY A. receive 3.03 office actions before reaching final disposition. This places the examiner in the 87% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by SASS, KIMBERLY A. is 42 months. This places the examiner in the 19% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +59.0% benefit to allowance rate for applications examined by SASS, KIMBERLY A.. This interview benefit is in the 96% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 17.2% of applications are subsequently allowed. This success rate is in the 15% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 15.0% of cases where such amendments are filed. This entry rate is in the 16% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
This examiner withdraws rejections or reopens prosecution in 25.0% of appeals filed. This is in the 3% percentile among all examiners. Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 114.3% are granted (fully or in part). This grant rate is in the 94% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 40% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 43% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.